Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, announced it had completed an initial supply agreement with Yuanshuo Medical Instruments Corporation (YMIC). YMIC is headquartered in Jiangsu province, China and is licensed by the Chinese government to sell and distribute both Class II and Class III medical devices. According to the agreement, YMIC will initially purchase $200,000 worth of LuViva devices and single-use components.

Additional orders are expected next year under a broader supply agreement currently under discussion. The new agreement with YMIC is in addition to the current agreement GTHP has with Hangzhou Dongye Medical Technology Company, Ltd. (HDMT) to provide them with 35 devices. HDMT is in Hangzhou City, Zhejiang Province, where it is the exclusive provider of gynecology products for 42 hospitals that perform approximately two million cervical cancer screenings annually.

“We are pleased to add a new partner that is eager to obtain and distribute our products in Jiangsu province, where we expect LuViva to find cervical cancer earlier and improve outcomes for the 137 million women who live there,” said Mark Faupel, CEO of Guided Therapeutics.